ID: ALA5181179

Max Phase: Preclinical

Molecular Formula: C50H64N10O7S

Molecular Weight: 949.19

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCn2cc(COC(=O)NCc3ccc(C(=O)Nc4ccccc4N)cc3)nn2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C50H64N10O7S/c1-33-44(68-32-54-33)36-21-17-34(18-22-36)27-52-47(64)42-26-39(61)30-60(42)48(65)45(50(2,3)4)56-43(62)16-10-8-6-5-7-9-13-25-59-29-38(57-58-59)31-67-49(66)53-28-35-19-23-37(24-20-35)46(63)55-41-15-12-11-14-40(41)51/h11-12,14-15,17-24,29,32,39,42,45,61H,5-10,13,16,25-28,30-31,51H2,1-4H3,(H,52,64)(H,53,66)(H,55,63)(H,56,62)/t39-,42+,45-/m1/s1

Standard InChI Key:  VCLKGDPCTKGOSX-BZPYCXPJSA-N

Associated Targets(Human)

VHL/Histone deacetylase 1 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 2 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 3 77 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 949.19Molecular Weight (Monoisotopic): 948.4680AlogP: 6.90#Rotatable Bonds: 22
Polar Surface Area: 235.79Molecular Species: NEUTRALHBA: 13HBD: 6
#RO5 Violations: 4HBA (Lipinski): 17HBD (Lipinski): 7#RO5 Violations (Lipinski): 4
CX Acidic pKa: 12.68CX Basic pKa: 3.27CX LogP: 5.22CX LogD: 5.22
Aromatic Rings: 5Heavy Atoms: 68QED Weighted: 0.03Np Likeness Score: -0.86

References

1. Cross JM, Coulson ME, Smalley JP, Pytel WA, Ismail O, Trory JS, Cowley SM, Hodgkinson JT..  (2022)  A 'click' chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras.,  13  (12.0): [PMID:36545434] [10.1039/d2md00199c]

Source